GSK stock falls more at London open following RSV vaccination news

GSK’s London-listed shares fell even more swiftly their ADRs to news that advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated against respiratory syncytial virus.

Previous post Micron investors will have to wait for 2025 for a bigger AI payoff
Next post H&M plunges 13% on doubts over full-year margin target, June sales outlook